ADAM17 (catalytic domain) (human), (recombinant) (His-tag)

Produktübersicht

• Artikelname: ADAM17 (catalytic domain) (human), (recombinant) (His-tag)
• Artikelnummer: ENZ-BML-SE268-0010
• Hersteller Artikelnummer: BML-SE268-0010
• Alternativnummer: ENZ-BML-SE268-0010-10
• Hersteller: Enzo Life Sciences
• Kategorie: Proteine/Peptide
• Alternative Synonym: TACE, A disintegrin and metalloproteinase 17, Tumor necrosis factor-alpha-converting enzyme

Produktbeschreibung

ADAM17 (catalytic domain) (human), (recombinant) (His-tag)

Produkteigenschaften

• Molekulargewicht: ~30.5kDa (calculated), ~36kDa doublet (SDS-PAGE)
• UniProt: P78536
• Quelle: Produced in insect cells. Produced in a baculovirus expression system.
• Reinheit: Purified by multi-step chromatography.
• Formulierung: Liquid. In 22.5mM TRIS, pH 7.5, containing 4.5µM ZnCl2, 0.0045% Brij-35 and 10% glycerol.
• Sequenz: Recombinant glycosylated catalytic domain (aa Pro18-Val477) of ADAM17/TACE (A disintegrin and metalloproteinase 17, Tumor necrosis factor-alpha-converting enzyme), cloned from human cDNA (NM_003183), secreted as mature, active enzyme from insect cells, an
• Target-Kategorie: ADAM| ADAM

Anwendungsbeschreibung

• Anwendungsbeschreibung: Useful tool to study enzyme kinetics, cleave target substrates, screen inhibitors.